发现好书期刊，享受阅读乐趣

海量图书期刊资源，随时随地畅享阅读乐趣

A cost-effectiveness analysis of Herceptin® (trastuzumab) in combination with Paclitaxel as a first line treatment for HER2 positive (3+) Metastatic Breast Cancer (MBC) patients in the UK

A cost-effectiveness analysis of Herceptin® (trastuzumab) in combination with Paclitaxel as a first line treatment for HER2 positive (3+) Metastatic Breast Cancer (MBC) patients in the UK

A. Ratcliffe; C. Poole; D. Miles

作者A. Ratcliffe; C. Poole; D. Miles
卷第37卷
印刷ISSN0959-8049
文件大小165.21KB
发表时间2001
DOI10.1016/s0959-8049(01)80043-5

← 返回【学霸图书馆】主页